• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.干扰素γ和肿瘤坏死因子并非疫苗控制结核病时CD4 + T细胞反应的必需参数。
J Infect Dis. 2015 Aug 1;212(3):495-504. doi: 10.1093/infdis/jiv055. Epub 2015 Jan 30.
2
Pulmonary immunity and durable protection induced by the ID93/GLA-SE vaccine candidate against the hyper-virulent Korean Beijing Mycobacterium tuberculosis strain K.ID93/GLA-SE候选疫苗诱导的针对高毒力韩国北京结核分枝杆菌菌株K的肺部免疫和持久保护作用
Vaccine. 2016 Apr 27;34(19):2179-87. doi: 10.1016/j.vaccine.2016.03.029. Epub 2016 Mar 20.
3
Quest for correlates of protection against tuberculosis.寻找结核病保护性关联因素
Clin Vaccine Immunol. 2015 Mar;22(3):258-66. doi: 10.1128/CVI.00721-14. Epub 2015 Jan 14.
4
Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.一种新型多阶段亚单位疫苗提供的针对结核分枝杆菌感染的保护作用与IFN-γ+ IL-2+ CD4+和IFN-γ+ CD8+ T细胞数量增加相关。
PLoS One. 2015 Mar 30;10(3):e0122560. doi: 10.1371/journal.pone.0122560. eCollection 2015.
5
Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.针对结核分枝杆菌隐匿表位的保护性 CD4 T 细胞可抵抗感染驱动的终末分化。
J Immunol. 2014 Apr 1;192(7):3247-58. doi: 10.4049/jimmunol.1300283. Epub 2014 Feb 26.
6
Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.疫苗诱导的抗结核保护性免疫与多功能 CD4 T 细胞的数量和质量有关。
Vaccine. 2011 Apr 5;29(16):2902-9. doi: 10.1016/j.vaccine.2011.02.010. Epub 2011 Feb 21.
7
Protein energy malnutrition during vaccination has limited influence on vaccine efficacy but abolishes immunity if administered during Mycobacterium tuberculosis infection.接种疫苗期间的蛋白质能量营养不良对疫苗效力影响有限,但如果在结核分枝杆菌感染期间接种则会消除免疫力。
Infect Immun. 2015 May;83(5):2118-26. doi: 10.1128/IAI.03030-14. Epub 2015 Mar 9.
8
Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.黏膜给药可将对佐剂性结核疫苗的反应从全身性Th1反应转变为组织驻留性Th17反应,而不影响其保护效力。
Vaccine. 2015 Nov 27;33(48):6570-8. doi: 10.1016/j.vaccine.2015.10.115. Epub 2015 Nov 3.
9
Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.源自结核分枝杆菌潜伏抗原Rv1733c的合成长肽可预防结核病。
Clin Vaccine Immunol. 2015 Sep;22(9):1060-9. doi: 10.1128/CVI.00271-15. Epub 2015 Jul 22.
10
A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.一种多阶段多表位疫苗可预防 HLA-DR3 转基因小鼠感染结核分枝杆菌。
Vaccine. 2012 Dec 14;30(52):7513-21. doi: 10.1016/j.vaccine.2012.10.045. Epub 2012 Oct 24.

引用本文的文献

1
Antigen-specific CD4+ T cells promote monocyte recruitment and differentiation into glycolytic lung macrophages to control Mycobacterium tuberculosis.抗原特异性CD4+ T细胞促进单核细胞募集并分化为糖酵解型肺巨噬细胞,以控制结核分枝杆菌。
PLoS Pathog. 2025 Jun 9;21(6):e1013208. doi: 10.1371/journal.ppat.1013208. eCollection 2025 Jun.
2
Immunopathology of Pulmonary Infection in a Humanized Mouse Model.人源化小鼠肺部感染的免疫病理学研究。
Int J Mol Sci. 2024 Jan 29;25(3):1656. doi: 10.3390/ijms25031656.
3
Statistical and network analyses reveal mechanisms for the enhancement of macrophage immunity by manganese in infection.统计分析和网络分析揭示了锰在感染中增强巨噬细胞免疫的机制。
Biochem Biophys Rep. 2023 Dec 20;37:101602. doi: 10.1016/j.bbrep.2023.101602. eCollection 2024 Mar.
4
Helper T cell bias following tuberculosis chemotherapy identifies opportunities for therapeutic vaccination to prevent relapse.结核病化疗后辅助性T细胞偏向性为预防性治疗性疫苗接种预防复发提供了机会。
NPJ Vaccines. 2023 Oct 28;8(1):165. doi: 10.1038/s41541-023-00761-4.
5
T cell transcription factor expression evolves over time in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques.结核分枝杆菌感染食蟹猴肉芽肿中 T 细胞转录因子的表达随时间演变。
Cell Rep. 2022 May 17;39(7):110826. doi: 10.1016/j.celrep.2022.110826.
6
BCG vaccination strategies against tuberculosis: updates and perspectives.BCG 疫苗接种策略防治结核病:更新与展望。
Hum Vaccin Immunother. 2021 Dec 2;17(12):5284-5295. doi: 10.1080/21645515.2021.2007711.
7
Prevention of tuberculosis in macaques after intravenous BCG immunization.静脉内 BCG 免疫后猕猴结核病的预防。
Nature. 2020 Jan;577(7788):95-102. doi: 10.1038/s41586-019-1817-8. Epub 2020 Jan 1.
8
Tuberculosis Vaccine Development: Progress in Clinical Evaluation.结核病疫苗研发:临床评估进展。
Clin Microbiol Rev. 2019 Oct 30;33(1). doi: 10.1128/CMR.00100-19. Print 2019 Dec 18.
9
Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.牛型分枝杆菌细胞壁骨架增强抗原 85B 对结核病的疫苗潜力,通过诱导 Th1 和 Th17 反应。
PLoS One. 2019 Mar 8;14(3):e0213536. doi: 10.1371/journal.pone.0213536. eCollection 2019.
10
Heterologous Boost Following Reduces the Late Persistent, Rather Than the Early Stage of Intranasal Tuberculosis Challenge Infection.异源加强接种可减少迟发性而非早期鼻内结核感染挑战。
Front Immunol. 2018 Oct 30;9:2439. doi: 10.3389/fimmu.2018.02439. eCollection 2018.

本文引用的文献

1
From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.从鼠到人:候选利什曼病疫苗 LEISH-F3+GLA-SE 的安全性、免疫原性和疗效。
Clin Transl Immunology. 2015 Apr 10;4(4):e35. doi: 10.1038/cti.2015.6. eCollection 2015 Apr.
2
Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.作为抗结核分枝杆菌疫苗候选物的免疫亚优势抗原
J Immunol. 2014 Sep 15;193(6):2911-8. doi: 10.4049/jimmunol.1401103. Epub 2014 Aug 1.
3
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球、区域和国家在 1990-2013 年间艾滋病毒、结核病和疟疾的发病率和死亡率:2013 年全球疾病负担研究的系统分析。
Lancet. 2014 Sep 13;384(9947):1005-70. doi: 10.1016/S0140-6736(14)60844-8. Epub 2014 Jul 22.
4
In search of a new paradigm for protective immunity to TB.寻找针对结核病的保护性免疫新范式。
Nat Rev Microbiol. 2014 Apr;12(4):289-99. doi: 10.1038/nrmicro3230. Epub 2014 Mar 3.
5
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.佐剂配方的结构和组成对于开发有效的结核病疫苗至关重要。
J Control Release. 2013 Nov 28;172(1):190-200. doi: 10.1016/j.jconrel.2013.07.030. Epub 2013 Aug 9.
6
Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cells.用同源或异源蛋白/载体疫苗方法预防结核病不依赖于 CD8+ T 细胞。
J Immunol. 2013 Sep 1;191(5):2514-2525. doi: 10.4049/jimmunol.1301161. Epub 2013 Jul 31.
7
Control of chronic mycobacterium tuberculosis infection by CD4 KLRG1- IL-2-secreting central memory cells.通过分泌 IL-2 的 CD4 KLRG1-中央记忆细胞控制慢性结核分枝杆菌感染。
J Immunol. 2013 Jun 15;190(12):6311-9. doi: 10.4049/jimmunol.1300248. Epub 2013 May 15.
8
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.新型结核疫苗 MVA85A 在既往接种过卡介苗婴儿中的安全性和有效性:一项随机、安慰剂对照的 2b 期试验。
Lancet. 2013 Mar 23;381(9871):1021-8. doi: 10.1016/S0140-6736(13)60177-4.
9
IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection.CD4 T 细胞产生的 IFN-γ 对于宿主的存活至关重要,并在结核分枝杆菌感染期间增强 CD8 T 细胞的功能。
J Immunol. 2013 Jan 1;190(1):270-7. doi: 10.4049/jimmunol.1200061. Epub 2012 Dec 10.
10
Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice.剖析结核分枝杆菌记忆 T 细胞应答:对采用过继转移至免疫缺陷小鼠方法的担忧。
Tuberculosis (Edinb). 2012 Sep;92(5):422-33. doi: 10.1016/j.tube.2012.05.008. Epub 2012 Jun 26.

干扰素γ和肿瘤坏死因子并非疫苗控制结核病时CD4 + T细胞反应的必需参数。

Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.

作者信息

Orr Mark T, Windish Hillarie Plessner, Beebe Elyse A, Argilla David, Huang Po-Wei D, Reese Valerie A, Reed Steven G, Coler Rhea N

机构信息

Infectious Disease Research Institute Department of Global Health, University of Washington, Seattle.

Infectious Disease Research Institute.

出版信息

J Infect Dis. 2015 Aug 1;212(3):495-504. doi: 10.1093/infdis/jiv055. Epub 2015 Jan 30.

DOI:10.1093/infdis/jiv055
PMID:25637347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4654754/
Abstract

BACKGROUND

Mycobacterium tuberculosis infects one third of the world's population and causes >8 million cases of tuberculosis annually. New vaccines are necessary to control the spread of tuberculosis. T cells, interferon γ (IFN-γ), and tumor necrosis factor (TNF) are necessary to control M. tuberculosis infection in both humans and unvaccinated experimental animal models. However, the immune responses necessary for vaccine efficacy against M. tuberculosis have not been defined. The multifunctional activity of T-helper type 1 (TH1) cells that simultaneously produce IFN-γ and TNF has been proposed as a candidate mechanism of vaccine efficacy.

METHODS

We used a mouse model of T-cell transfer and aerosolized M. tuberculosis infection to assess the contributions of TNF, IFN-γ, and inducible nitric oxide synthase (iNOS) to vaccine efficacy.

RESULTS

CD4(+) T cells were necessary and sufficient to transfer protection against aerosolized M. tuberculosis, but neither CD4(+) T cell-produced TNF nor host cell responsiveness to IFN-γ were necessary. Transfer of Tnf(-/-) CD4(+) T cells from vaccinated donors to Ifngr(-/-) recipients was also sufficient to confer protection. Activation of iNOS to produce reactive nitrogen species was not necessary for vaccine efficacy.

CONCLUSIONS

Induction of TH1 cells that coexpress IFN-γ and TNF is not a requirement for vaccine efficacy against M. tuberculosis, despite these cytokines being essential for control of M. tuberculosis in nonvaccinated animals.

摘要

背景

结核分枝杆菌感染了世界三分之一的人口,每年导致超过800万例结核病。需要新的疫苗来控制结核病的传播。在人类和未接种疫苗的实验动物模型中,T细胞、干扰素γ(IFN-γ)和肿瘤坏死因子(TNF)对于控制结核分枝杆菌感染是必需的。然而,针对结核分枝杆菌疫苗效力所必需的免疫反应尚未明确。同时产生IFN-γ和TNF的1型辅助性T细胞(TH1)的多功能活性已被提出作为疫苗效力的候选机制。

方法

我们使用T细胞转移和雾化结核分枝杆菌感染的小鼠模型来评估TNF、IFN-γ和诱导型一氧化氮合酶(iNOS)对疫苗效力的作用。

结果

CD4(+) T细胞对于转移针对雾化结核分枝杆菌的保护是必要且充分的,但CD4(+) T细胞产生的TNF和宿主细胞对IFN-γ的反应性均不是必需的。将接种疫苗供体的Tnf(-/-) CD4(+) T细胞转移到Ifngr(-/-)受体也足以赋予保护。激活iNOS以产生活性氮物质对于疫苗效力不是必需的。

结论

尽管这些细胞因子对于未接种疫苗动物控制结核分枝杆菌至关重要,但共表达IFN-γ和TNF的TH1细胞的诱导对于抗结核分枝杆菌疫苗效力并非必需。